Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen Resolves Repatha Access Kerfuffle With Express Scripts

Executive Summary

On eve of congressional hearing, the pharmacy benefit manager assures Amgen that Repatha is available to its employees.

Advertisement

Related Content

Pfizer, Express Scripts Clash Over Biosimilar Formulary Placement
Senate Panel Questions Early PBM Response To Repatha Price Cut
Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS125270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel